GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 785 filers reported holding GLAXOSMITHKLINE PLC in Q1 2018. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $201,000 | -50.1% | 5,310 | -38.1% | 0.07% | -41.9% |
| Q4 2019 | $403,000 | +59.3% | 8,582 | +44.8% | 0.12% | +45.9% |
| Q3 2019 | $253,000 | -2.3% | 5,926 | -8.5% | 0.08% | -1.2% |
| Q2 2019 | $259,000 | -7.8% | 6,477 | -3.6% | 0.09% | -11.3% |
| Q1 2019 | $281,000 | -74.3% | 6,719 | -76.5% | 0.10% | -78.3% |
| Q4 2018 | $1,092,000 | -0.5% | 28,567 | +4.6% | 0.45% | +17.6% |
| Q3 2018 | $1,097,000 | -11.8% | 27,304 | -11.5% | 0.38% | -19.5% |
| Q2 2018 | $1,244,000 | +4.7% | 30,849 | +1.5% | 0.47% | -1.9% |
| Q1 2018 | $1,188,000 | +8.2% | 30,403 | -1.8% | 0.48% | +4.3% |
| Q4 2017 | $1,098,000 | +0.5% | 30,960 | +15.1% | 0.46% | -5.3% |
| Q3 2017 | $1,093,000 | -7.1% | 26,909 | -1.3% | 0.49% | -16.9% |
| Q2 2017 | $1,176,000 | +5.8% | 27,275 | +3.4% | 0.59% | +1.7% |
| Q1 2017 | $1,112,000 | +29.5% | 26,382 | +18.3% | 0.58% | +11.0% |
| Q4 2016 | $859,000 | – | 22,309 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |